---
figid: PMC11101339__41417_2024_732_Fig4_HTML
figtitle: KRAS pathway and KRAS inhibitors
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11101339
filename: 41417_2024_732_Fig4_HTML.jpg
figlink: /pmc/articles/PMC11101339/figure/F4
number: F4
caption: KRASG12C inhibitors selectively and irreversibly binds KRASG12C in its inactive
  GDP state
papertitle: 'The golden key to open mystery boxes of SMARCA4-deficient undifferentiated
  thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation'
reftext: Xiang Li, et al. Cancer Gene Ther. 2024 Feb 13;31(5).
year: '2024'
doi: 10.1038/s41417-024-00732-4
journal_title: Cancer Gene Therapy
journal_nlm_ta: Cancer Gene Ther
publisher_name: Nature Publishing Group US
keywords: Non-small-cell lung cancer | Cancer microenvironment | Cancer immunotherapy
automl_pathway: 0.9487307
figid_alias: PMC11101339__F4
figtype: Figure
redirect_from: /figures/PMC11101339__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11101339__41417_2024_732_Fig4_HTML.html
  '@type': Dataset
  description: KRASG12C inhibitors selectively and irreversibly binds KRASG12C in
    its inactive GDP state
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTPN11
  - KRAS
  - NRAS
  - MTG1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RALGDS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - RALA
  - RALB
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - GTP
  - GDP
  - MEK
  - inhibitors
---
